CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-α2a as first line treatment in metastatic melanoma
Author
Hernberg Micaela
Ivaska Johanna
+6 more
Laukka Marjut
Lundin Johan
Pyrhönen Seppo
Tyynelä Kristiina
Vihinen Pia P.
Vuoristo Meri-Sisko
Publication venue
Publication date
01/01/2010
Field of study
No full text
VTT Research System